Current Value of Holding

$121 Million

Shares

12.8 Million

% of Portfolio

1.09%

Average Buy Price

$69.4

Avg closing price
Price range

20 Cathie Wood 10x Genomics Trades

Cathie Wood's position in 10x Genomics is currently worth $121 Million. That's 1.09% of their equity portfolio (25th largest holding). The investor owns 10.29% of the outstanding 10x Genomics stock. The first 10x Genomics trade was made in Q2 2020. Since then Cathie Wood bought shares twelve more times and sold shares on seven occasions. The investor's estimated purchase price is $892 Million, resulting in a loss of 86%.

Avg closing price
Price range
Increased shares by 7.5% (+902 Thousand shares) Q1 2025
Avg closing price $12.69
Price range $8.73 - $16.31
Increased shares by 11.1% (+1.19 Million shares) Q4 2024
Avg closing price $15.76
Price range $13.18 - $21.31
Increased shares by 15.4% (+1.44 Million shares) Q3 2024
Avg closing price $20.69
Price range $15.71 - $23.49
Increased shares by 48.2% (+3.03 Million shares) Q2 2024
Avg closing price $26.19
Price range $19.45 - $37.37
Increased shares by 55.5% (+2.24 Million shares) Q1 2024
Avg closing price $43.94
Price range $36.08 - $54.30
Increased shares by 35.0% (+1.05 Million shares) Q4 2023
Avg closing price $43.51
Price range $34.32 - $57.55
Sold 3.9% shares (-120 Thousand shares) Q3 2023
Avg closing price $52.02
Price range $40.86 - $62.98
Sold 25.1% shares (-1.04 Million shares) Q2 2023
Avg closing price $54.12
Price range $50.96 - $58.72
Sold 3.7% shares (-161 Thousand shares) Q1 2023
Avg closing price $46.70
Price range $35.33 - $55.79
Sold 5.7% shares (-260 Thousand shares) Q4 2022
Avg closing price $32.70
Price range $24.40 - $41.30
Increased shares by 27.0% (+974 Thousand shares) Q3 2022
Avg closing price $38.10
Price range $28.48 - $52.59
Increased shares by 6.2% (+212 Thousand shares) Q2 2022
Avg closing price $51.88
Price range $36.95 - $82.41
Increased shares by 27.5% (+730 Thousand shares) Q1 2022
Avg closing price $87.48
Price range $55.70 - $145.79
Sold 14.2% shares (-441 Thousand shares) Q4 2021
Avg closing price $153.17
Price range $135.05 - $182.59
Sold 27.9% shares (-1.2 Million shares) Q3 2021
Avg closing price $171.69
Price range $145.58 - $192.14
Increased shares by 22.7% (+796 Thousand shares) Q2 2021
Avg closing price $180.98
Price range $134.22 - $202.37
Increased shares by 556.8% (+2.97 Million shares) Q1 2021
Avg closing price $172.69
Price range $140.25 - $196.86
Increased shares by 130.9% (+302 Thousand shares) Q4 2020
Avg closing price $145.11
Price range $126.47 - $163.70
Sold 31.3% shares (-105 Thousand shares) Q3 2020
Avg closing price $104.97
Price range $87.44 - $125.00
New holding (+337 Thousand shares) Q2 2020
Avg closing price $77.89
Price range $58.39 - $89.31

News about 10x Genomics Inc - Ordinary Shares - Class A and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!